ANITA DESWAL to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications ANITA DESWAL has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.397
-
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
Score: 0.126
-
Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010 Jul; 15(4):331-41.
Score: 0.067
-
Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest. 2003 Mar; 123(3):716-24.
Score: 0.041
-
Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial. Chest. 2001 Aug; 120(2):453-9.
Score: 0.036
-
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001 Apr 24; 103(16):2055-9.
Score: 0.036
-
The role of anti-cytokine therapy in the failing heart. Heart Fail Rev. 2001 Mar; 6(2):143-51.
Score: 0.035
-
An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol. 1999 May; 14(3):206-10.
Score: 0.031
-
New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail. 2011 Jul; 4(4):456-62.
Score: 0.018
-
The role of cytokines in disease progression in heart failure. Curr Opin Cardiol. 1997 May; 12(3):218-23.
Score: 0.007